| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Erick D. Bothun | Q113157148 |
| P2093 | author name string | Michael S Lee | |
| Andrew R Harrison | |||
| Ryan A Scheurer | |||
| P2860 | cites work | Graves' ophthalmopathy--immunologic parameters related to corticosteroid therapy | Q39109842 |
| Graves' ophthalmopathy: current concepts regarding pathogenesis and management | Q39489563 | ||
| Evolution of classification systems for Graves' ophthalmopathy. | Q41069639 | ||
| Treating severe Graves' ophthalmopathy | Q41734163 | ||
| Orbital steroid injections | Q43007530 | ||
| Comparison of the effectiveness and tolerability of intravenous or oral glucocorticoids associated with orbital radiotherapy in the management of severe Graves' ophthalmopathy: results of a prospective, single-blind, randomized study | Q43705603 | ||
| Use of corticosteroids to prevent progression of Graves' ophthalmopathy after radioiodine therapy for hyperthyroidism | Q43907362 | ||
| Orbital irradiation for Graves' ophthalmopathy: Is it safe? A long-term follow-up study | Q45003668 | ||
| Orbital decompression for Graves' ophthalmopathy by inferomedial, by inferomedial plus lateral, and by coronal approach | Q45235954 | ||
| The lacrimal keyhole, orbital door jamb, and basin of the inferior orbital fissure. Three areas of deep bone in the lateral orbit | Q46102491 | ||
| Primary-gaze diplopia in patients with thyroid-related orbitopathy undergoing deep lateral orbital decompression with intraconal fat debulking: a retrospective analysis of treatment outcome | Q46174774 | ||
| A prospective study of the effects of radioiodine therapy for hyperthyroidism in patients with minimally active graves' ophthalmopathy | Q46572783 | ||
| Randomized, single blind trial of intravenous versus oral steroid monotherapy in Graves' orbitopathy | Q46585048 | ||
| Early response to intravenous glucocorticoids for severe thyroid-associated ophthalmopathy predicts treatment outcome | Q46665392 | ||
| Surgical or medical decompression as a first-line treatment of optic neuropathy in Graves' ophthalmopathy? A randomized controlled trial | Q46665485 | ||
| Methylprednisolone pulse therapy for patients with moderately severe Graves' orbitopathy: a prospective, randomized, placebo-controlled study | Q46784134 | ||
| Clinical features of Graves' ophthalmopathy in an incidence cohort | Q28275743 | ||
| Clinical criteria for the assessment of disease activity in Graves' ophthalmopathy: a novel approach | Q33647383 | ||
| Management of Graves' ophthalmopathy: reality and perspectives | Q33899550 | ||
| Thyroid-associated ophthalmopathy: clinical features, pathogenesis, and management | Q34147441 | ||
| Controversies in the clinical evaluation of active thyroid-associated orbitopathy: use of a detailed protocol with comparative photographs for objective assessment. | Q34394088 | ||
| Long-term results of irradiation for patients with progressive Graves' ophthalmopathy | Q34430156 | ||
| Development of a disease specific quality of life questionnaire for patients with Graves' ophthalmopathy: the GO-QOL. | Q35305938 | ||
| Impact of smoking on the response to treatment of thyroid associated ophthalmopathy | Q35591093 | ||
| Treatment of thyroid associated ophthalmopathy with periocular injections of triamcinolone | Q35592595 | ||
| Clinical features of dysthyroid optic neuropathy: a European Group on Graves' Orbitopathy (EUGOGO) survey | Q36014781 | ||
| Long-term Results of Adjustable Suture Surgery for Strabismus Secondary to Thyroid Ophthalmopathy | Q36322322 | ||
| Clinical assessment of patients with Graves' orbitopathy: the European Group on Graves' Orbitopathy recommendations to generalists, specialists and clinical researchers | Q36568033 | ||
| Susceptibility genes in Graves' ophthalmopathy: searching for a needle in a haystack? | Q36830207 | ||
| Orbital radiation for graves ophthalmopathy: a report by the American Academy of Ophthalmology | Q37033302 | ||
| Consensus statement of the European group on Graves' orbitopathy (EUGOGO) on management of Graves' orbitopathy | Q37110191 | ||
| Clinical activity score as a guide in the management of patients with Graves' ophthalmopathy. | Q50933902 | ||
| Orbital fat removal. Decompression for Graves orbitopathy. | Q51664950 | ||
| Graves ophthalmopathy: MR evaluation of 10-Gy versus 24-Gy irradiation combined with systemic corticosteroids. | Q54164036 | ||
| Occurrence of Ophthalmopathy after Treatment for Graves' Hyperthyroidism | Q57482592 | ||
| Acute and Severe Liver Damage Associated with Intravenous Glucocorticoid Pulse Therapy in Patients with Graves' Ophthalmopathy | Q61054093 | ||
| Influences of Age, Gender, Smoking, and Family History on Autoimmune Thyroid Disease Phenotype | Q62000551 | ||
| Effect of Abnormal Thyroid Function on the Severity of Graves' Ophthalmopathy | Q67657511 | ||
| Orbital radiotherapy combined with high dose systemic glucocorticoids for Graves' ophthalmopathy is more effective than radiotherapy alone: results of a prospective randomized study | Q67876001 | ||
| Orbital cobalt irradiation combined with retrobulbar or systemic corticosteroids for Graves' ophthalmopathy: a comparative study | Q68187821 | ||
| Prednisone and cyclosporine in the treatment of severe Graves' ophthalmopathy | Q69288448 | ||
| The four stages of surgical rehabilitation of the patient with dysthyroid ophthalmopathy | Q69498905 | ||
| Ophthalmopathy of Graves' disease: computerized volume measurements of the orbital fat and muscle | Q70297118 | ||
| Injection treatment of endocrine orbital myopathy | Q70643761 | ||
| Ocular surface drying and tear film osmolarity in thyroid eye disease | Q71244779 | ||
| Smoking and endocrine ophthalmopathy: impact of smoking severity and current vs lifetime cigarette consumption | Q71871480 | ||
| Randomized double-blind trial of prednisone versus radiotherapy in Graves' ophthalmopathy | Q72235149 | ||
| Classification of the eye changes of Grave's disease | Q72526853 | ||
| Age and gender influence the severity of thyroid-associated ophthalmopathy: a study of 101 patients attending a combined thyroid-eye clinic | Q72800952 | ||
| Low- versus high-dose radiotherapy for Graves' ophthalmopathy: a randomized, single blind trial | Q73351501 | ||
| The risk of diplopia following orbital floor and medial wall decompression in subtypes of ophthalmic Graves' disease | Q73719202 | ||
| Radiotherapy for Graves' orbitopathy: randomised placebo-controlled study | Q73761107 | ||
| Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy | Q74010201 | ||
| Treatment of upper eyelid retraction associated with thyroid eye disease with subconjunctival botulinum toxin injection | Q74228903 | ||
| Thyrotropin receptor expression in Graves' orbital adipose/connective tissues: potential autoantigen in Graves' ophthalmopathy | Q74324679 | ||
| A prospective, randomized, double-blind, placebo-controlled study of orbital radiotherapy for Graves' ophthalmopathy | Q74459180 | ||
| Effects of total thyroid ablation versus near-total thyroidectomy alone on mild to moderate Graves' orbitopathy treated with intravenous glucocorticoids | Q79771160 | ||
| Treatment-resistant severe, active Graves' ophthalmopathy successfully treated with B lymphocyte depletion | Q80061323 | ||
| The influence of previous orbital irradiation on the outcome of rehabilitative decompression surgery in graves orbitopathy | Q80483336 | ||
| The effect of etanercept on Graves' ophthalmopathy: a pilot study | Q81024281 | ||
| Development and course of exophthalmos and ophthalmoplegia in Graves' disease with special reference to the effect of thyroidectomy | Q82104621 | ||
| Combined endoscopic medial and external lateral orbital decompression for progressive thyroid eye disease | Q82457493 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | eye disease | Q3041498 |
| P304 | page(s) | 543-551 | |
| P577 | publication date | 2009-10-19 | |
| P1433 | published in | Clinical Ophthalmology | Q5133782 |
| P1476 | title | Update on thyroid eye disease and management | |
| P478 | volume | 3 |
| Q92543279 | Correlation of peripapillary nerve fiber layer thickness with visual outcomes after decompression surgery in subclinical and clinical thyroid-related compressive optic neuropathy |
| Q48227443 | Fractional anisotropy and diffusivity changes in thyroid-associated orbitopathy. |
| Q37021603 | Postoperative drift in patients with thyroid ophthalmopathy undergoing unilateral inferior rectus muscle recession |
| Q55425970 | Prevalence and severity of ocular involvement in Graves' disease according to sex and age: A clinical study from Babol, Iran. |
| Q37325127 | The Change of Lacrimal Gland Volume in Korean Patients with Thyroid-associated Ophthalmopathy |
| Q34871250 | The relationship between Graves' ophthalmopathy and dry eye syndrome |
| Q91789199 | Thyroid Eye Disease: How A Novel Therapy May Change The Treatment Paradigm |
Search more.